OBIO: Orchestra BioMed Holdings Inc Company Profile & Statistics

About

Orchestra BioMed Inc. is a biomedical company accelerating high-impact technologies to patients. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy(TM)for the treatment of hypertension and Virtue(R) Sirolimus AngioInfusion(TM) Balloon for the treatment of atherosclerotic artery disease. Orchestra BioMed Inc., formerly known as Health Sciences Acquisitions Corporation 2, is based in NEW HOPE, Pa.

Info & Links

CEO

David P. Hochman

Headquarters

150 UNION SQUARE DRIVE
NEW HOPE, PA 18938, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

595

Employees

Orchestra BioMed Holdings Inc Statistics

Valuation Measures

Market Capitalization²

180.55M

Enterprise Value

154.94M

Enterprise Value/EBITDA(ttm)

-2.59

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

75.54

Price to Book(mrq)

4.30

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

91.01%

Operating Margin(ttm)

-2179.33%

Profit Margin(ttm)

-2670.18%

Return on Equity(ttm)

-107.04%

Return on Invested Capital(ttm)

-111.97%

Return on Assets(ttm)

-70.88%

Income Statement

Revenue(ttm)

2.65M

Revenue Per Share(ttm)

0.07

Gross Profit(ttm)

2.45M

EBITDA(ttm)³

-59.81M

Net Income Available to Common(ttm)

-57.69M

Diluted EPS(ttm)

-1.61

Share Statistics

Beta (5Y Monthly)

0.44

52-Week Change

-35.02%

S&P 500 52-Week Change

27.90%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

38.01M

Dividend Yield

0.00%

Float⁴

35.47M

% Held by Insiders

6.70%

% Held by Institutions

53.55%

Balance Sheet

Total Cash(mrq)

66.93M

Total Cash Per Share(mrq)

1.76

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.23%

Quick Ratio(mrq)

4.21%

Book Value Per Share(mrq)

1.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.98

Free Cash Flow(ytd)

-37.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

OBIO

Orchestra BioMed Holdings Inc

Orchestra BioMed Holdings Inc Profile